DE2752728C2 - Pharmazeutische Zubereitung mit verzögerter Abgabe - Google Patents

Pharmazeutische Zubereitung mit verzögerter Abgabe

Info

Publication number
DE2752728C2
DE2752728C2 DE2752728A DE2752728A DE2752728C2 DE 2752728 C2 DE2752728 C2 DE 2752728C2 DE 2752728 A DE2752728 A DE 2752728A DE 2752728 A DE2752728 A DE 2752728A DE 2752728 C2 DE2752728 C2 DE 2752728C2
Authority
DE
Germany
Prior art keywords
resin
drug
complex
coating
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2752728A
Other languages
German (de)
English (en)
Other versions
DE2752728A1 (de
Inventor
Yegnaswami Fairport N.Y. Raghunathan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Corp
Original Assignee
Pennwalt Corp Philadelphia Pa
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp Philadelphia Pa, Pennwalt Corp filed Critical Pennwalt Corp Philadelphia Pa
Publication of DE2752728A1 publication Critical patent/DE2752728A1/de
Application granted granted Critical
Publication of DE2752728C2 publication Critical patent/DE2752728C2/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2752728A 1976-11-26 1977-11-25 Pharmazeutische Zubereitung mit verzögerter Abgabe Expired DE2752728C2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74532576A 1976-11-26 1976-11-26
US80010577A 1977-05-24 1977-05-24

Publications (2)

Publication Number Publication Date
DE2752728A1 DE2752728A1 (de) 1978-06-01
DE2752728C2 true DE2752728C2 (de) 1985-08-01

Family

ID=27114439

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2752728A Expired DE2752728C2 (de) 1976-11-26 1977-11-25 Pharmazeutische Zubereitung mit verzögerter Abgabe

Country Status (21)

Country Link
JP (1) JPS609697B2 (enExample)
AR (1) AR218047A1 (enExample)
AT (1) AT359197B (enExample)
AU (1) AU511080B2 (enExample)
BE (1) BE861141A (enExample)
CA (1) CA1086226A (enExample)
CH (1) CH639560A5 (enExample)
DE (1) DE2752728C2 (enExample)
DK (1) DK150534C (enExample)
FI (1) FI65910C (enExample)
FR (1) FR2373288A1 (enExample)
GB (1) GB1544761A (enExample)
GR (1) GR61724B (enExample)
IE (1) IE45998B1 (enExample)
IL (1) IL53462A (enExample)
LU (1) LU78584A1 (enExample)
NL (1) NL182283C (enExample)
NO (1) NO147626C (enExample)
NZ (1) NZ185772A (enExample)
PT (1) PT67323B (enExample)
SE (1) SE426781B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2929456A1 (de) 1979-07-20 1981-02-05 Lentia Gmbh Zusammensetzung mit verlaengerter broncholytischer und tokolytischer wirksamkeit, ein verfahren zu deren herstellung und broncholytisch und tokolytisch wirkendes mittel
CA1236023A (en) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Controlled release pharmaceutical preparations
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5188825A (en) * 1989-12-28 1993-02-23 Iles Martin C Freeze-dried dosage forms and methods for preparing the same
US5876752A (en) * 1990-08-07 1999-03-02 Pfizer Inc. Use of interfacially-polymerized membranes in delivery devices
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
US20130230587A1 (en) * 2010-11-10 2013-09-05 Rubicon Research Private Limited Sustained release compositions
FR3059903B1 (fr) * 2016-12-08 2019-03-22 Salsarulo Pharma Medicament oral comprenant un laxatif osmotique incorpore dans une matrice a base de matieres grasses vegetales
EP3694555A4 (en) 2017-10-09 2021-07-07 Rhodes Pharmaceuticals L.P. RESINATE-BASED PHARMACEUTICAL COMPOSITIONS AND THEIR MANUFACTURING AND USE PROCESSES
WO2020234842A1 (en) * 2019-05-23 2020-11-26 G.D Societa' Per Azioni Filling unit to fill a container, in particular a cartridge, with a liquid product of the pharmaceutical industry

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE550150A (enExample) * 1955-08-08
GB843118A (en) * 1957-02-13 1960-08-04 Ici Ltd Pharmaceutical compositions containing piperidine derivatives
US3158538A (en) * 1961-02-23 1964-11-24 White Lab Inc Antidiarrheal compositions and method of using
GB982150A (en) * 1961-09-29 1965-02-03 Glaxo Group Ltd Therapeutic resin complexes
US3594470A (en) * 1968-02-19 1971-07-20 Abbott Lab Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin
GB1218102A (en) * 1968-03-15 1971-01-06 Philips Nv Improvements in medicaments comprising drug/ion-exchange resin compounds
CA935092A (en) * 1968-09-03 1973-10-09 S. Banker Gilbert Molecular drug entrapment process and compositions
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS-ERMITTELT

Also Published As

Publication number Publication date
SE7713370L (sv) 1978-05-27
NO147626B (no) 1983-02-07
PT67323A (en) 1977-12-01
SE426781B (sv) 1983-02-14
BE861141A (fr) 1978-03-16
AR218047A1 (es) 1980-05-15
AT359197B (de) 1980-10-27
NL7712996A (nl) 1978-05-30
NO147626C (no) 1983-05-25
ATA848077A (de) 1980-03-15
DK150534C (da) 1987-10-12
PT67323B (en) 1979-04-24
JPS609697B2 (ja) 1985-03-12
GB1544761A (en) 1979-04-25
GR61724B (en) 1978-12-29
DE2752728A1 (de) 1978-06-01
AU3098677A (en) 1979-05-31
FI773568A7 (fi) 1978-05-27
CH639560A5 (en) 1983-11-30
LU78584A1 (enExample) 1978-04-20
FR2373288A1 (fr) 1978-07-07
JPS5369822A (en) 1978-06-21
NL182283C (nl) 1988-02-16
FI65910B (fi) 1984-04-30
AU511080B2 (en) 1980-07-24
FI65910C (fi) 1984-08-10
IE45998B1 (en) 1983-01-26
NZ185772A (en) 1978-12-18
CA1086226A (en) 1980-09-23
IE45998L (en) 1978-05-26
NL182283B (nl) 1987-09-16
DK150534B (da) 1987-03-23
FR2373288B1 (enExample) 1980-06-13
IL53462A0 (en) 1978-01-31
NO774051L (no) 1978-05-29
IL53462A (en) 1980-12-31
DK523277A (da) 1978-05-27

Similar Documents

Publication Publication Date Title
DE69423028T3 (de) Zubereitung mit kontrollierter freisetzung, die ein morphinsalz enthält
DE69721845T2 (de) Orale morphinzubereitung in teilchenform
DE3688532T2 (de) Pharmazeutische darreichungsform mit verzoegerter abgabe.
EP0299211B1 (de) DHP-Manteltablette
DE69811855T2 (de) Fenofibrathaltige arzneizusammensetzung mit hoher bioverfügbarkeit und herstellungsverfahren
DE69011588T2 (de) Pharmazeutische Formulierungen mit anhaltender Freisetzung.
DE2845326C2 (de) Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
CH641357A5 (de) Pharmazeutisches praeparat mit polymerbeschichtungen, enthaltend herzglykoside.
DE1106454B (de) UEberzugsmittel fuer Arzneistoffe
EP0519870A1 (de) Neue orale Diclofenaczubereitung
DE3524572A1 (de) Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
AT6542U1 (de) Tamsulosinpellets und verfahren zum herstellen derselben
DE3877331T2 (de) Exifon und ein wasserloesliches polymer enthaltende pharmazeutische zubereitung.
DE2752728C2 (de) Pharmazeutische Zubereitung mit verzögerter Abgabe
EP0250648B1 (de) Pharmazeutisches Präparat zur verzögerten Freigabe von Ibuprofen
DE69324214T2 (de) Pharmazeutische flüssige Suspensionszusammensetzung mit kontrollierter Freigabe
DE3853341T2 (de) Form zur verzögerten Diltiazemfreisetzung sowie das daraus hergestellte Arzneimittel.
CH641358A5 (de) Pharmazeutisches praeparat, enthaltend ein herzglykosid in kombination mit einem polymeren und verfahren zur herstellung desselben.
DE69813872T2 (de) Komplex aus carrageenan und einem wasserlöslichen medikament mit einer spezifischen granulometrie und entsprechende pharmazeutische zusammensetzungen mit gesteuerter freisetzung
EP0306699A1 (de) Dihydropyridin-Retard-Zubereitung
DE69327745T2 (de) Tablette zur langsamen Freisetzung von Natriumvalproat
CH629386A5 (de) Fuer die orale verabreichung bestimmtes granulat eines arzneimittels.
DE1492253A1 (de) Verfahren zur Herstellung von Tabletten mit protrahierter Wirkung
DE2615336C3 (de) Verfahren zum Gewinnen von leicht absorbierbarem Steringlykosid
CH638398A5 (de) Verfahren zur herstellung von eine pharmazeutische verbindung enthaltenden mikrokapseln.

Legal Events

Date Code Title Description
OD Request for examination
D2 Grant after examination
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: FISONS CORP. (N.D.GES.D. STAATES MASSACHUSETTS), R

8328 Change in the person/name/address of the agent

Free format text: ABITZ, W., DIPL.-ING.DR.-ING. MORF, D., DR. GRITSCHNEDER, M., DIPL.-PHYS. FRHR. VON WITTGENSTEIN, A., DIPL.-CHEM. DR.PHIL.NAT., PAT.-ANWAELTE, 8000 MUENCHEN